![Virginia Kirby](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Virginia Kirby
Direktor/Vorstandsmitglied bei NYXOAH SA
Vermögen: 283 986 $ am 31.05.2024
Profil
Virginia M.
Kirby is an Independent Non-Executive Director at Nyxoah SA since 2022 and a Director at Minneapolis Heart Institute Foundation, Inc. since 2021.
She previously held positions as Vice President-Clinical Affairs & Reimbursement at EnteroMedics, Inc. from 2005 to 2006, Vice President-Clinical Affairs & Reimbursement at ev3, Inc. from 2003 to 2005, Vice President-Clinical & Regulatory Affairs at Apnex Medical, Inc. from 2007 to 2013, and Senior VP-Clinical & Regulatory Affairs at Huinno, Inc. (United States) from 2016 to 2017.
Ms. Kirby obtained a graduate degree from Purdue University and undergraduate and graduate degrees from the University of Minnesota.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
NYXOAH SA
0,09% | 18.03.2024 | 30 560 ( 0,09% ) | 283 986 $ | 31.05.2024 |
Aktive Positionen von Virginia Kirby
Unternehmen | Position | Beginn |
---|---|---|
NYXOAH SA | Direktor/Vorstandsmitglied | 08.06.2022 |
Minneapolis Heart Institute Foundation, Inc. | Direktor/Vorstandsmitglied | 01.04.2021 |
Ehemalige bekannte Positionen von Virginia Kirby
Unternehmen | Position | Ende |
---|---|---|
Huinno, Inc. (United States)
![]() Huinno, Inc. (United States) Electronic Equipment/InstrumentsElectronic Technology Part of HUINNO Co., Ltd., Huinno, Inc. develops wearable technology and artificial intelligence based analytics to prevent cardiac diseases. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2017 |
Apnex Medical, Inc.
![]() Apnex Medical, Inc. Medical SpecialtiesHealth Technology Apnex Medical, Inc. manufactured medical devices. It developed a proprietary active implantable medical device for the treatment of obstructive sleep apnea (OSA). The company was founded by Chad J. Kugler, Michael L. Berman and Robert E. Atkinson in 2006 and was headquartered in St. Paul, MN. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2013 |
EnteroMedics, Inc.
![]() EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2006 |
ev3, Inc.
![]() ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2005 |
Ausbildung von Virginia Kirby
Purdue University | Graduate Degree |
University of Minnesota | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NYXOAH SA | Health Technology |
Private Unternehmen | 5 |
---|---|
ev3, Inc.
![]() ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | Health Technology |
Apnex Medical, Inc.
![]() Apnex Medical, Inc. Medical SpecialtiesHealth Technology Apnex Medical, Inc. manufactured medical devices. It developed a proprietary active implantable medical device for the treatment of obstructive sleep apnea (OSA). The company was founded by Chad J. Kugler, Michael L. Berman and Robert E. Atkinson in 2006 and was headquartered in St. Paul, MN. | Health Technology |
EnteroMedics, Inc.
![]() EnteroMedics, Inc. Medical SpecialtiesHealth Technology EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN. | Health Technology |
Minneapolis Heart Institute Foundation, Inc. | |
Huinno, Inc. (United States)
![]() Huinno, Inc. (United States) Electronic Equipment/InstrumentsElectronic Technology Part of HUINNO Co., Ltd., Huinno, Inc. develops wearable technology and artificial intelligence based analytics to prevent cardiac diseases. | Electronic Technology |